Top 10 Medical Equipment Stocks with Highest Upside: UNIS, APT, MELA, VSCI, DSCI, WHRT, ICAD, ISR, CRDC, GNMK (Mar 28, 2011)

Below are the top 10 Medical Equipment stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price.

Unilife Corp (NASDAQ:UNIS) has the 1st highest upside potential in this segment of the market. Its upside is 1079.8%. Its consensus target price 

is $10.50 based on the average of all estimates. Alpha Pro Tech, Ltd. (AMEX:APT) has the 2nd highest upside potential in this segment of the market. Its upside is 553.2%. Its consensus target price is $8.75 based on the average of all estimates. MELA Sciences, Inc. (NASDAQ:MELA) has the 3rd highest upside potential in this segment of the market. Its upside is 253.7%. Its consensus target price is $11.00 based on the average of all estimates.Vision-Sciences, Inc. (NASDAQ:VSCI) has the 4th highest upside potential in this segment of the market. Its upside is 185.7%. Its consensus target price is $6.00 based on the average of all estimates. Derma Sciences, Inc. (NASDAQ:DSCI) has the 5th highest upside potential in this segment of the market. Its upside is 173.5%. Its consensus target price is $25.00 based on the average of all estimates.

WorldHeart Corporation (USA) (NASDAQ:WHRT) has the 6th highest upside potential in this segment of the market. Its upside is 136.2%. Its consensus target price is $3.00 based on the average of all estimates. iCAD, INC. (NASDAQ:ICAD) has the 7th highest upside potential in this segment of the market. Its upside is 129.4%. Its consensus target price is $2.50 based on the average of all estimates. IsoRay, Inc. (AMEX:ISR) has the 8th highest upside potential in this segment of the market. Its upside is 119.3%. Its consensus target price is $2.50 based on the average of all estimates. Cardica, Inc. (NASDAQ:CRDC) has the 9th highest upside potential in this segment of the market. Its upside is 113.7%. Its consensus target price is $7.50 based on the average of all estimates.GenMark Diagnostics, Inc (NASDAQ:GNMK) has the 10th highest upside potential in this segment of the market. Its upside is 99.5%. Its consensus target price is $8.00 based on the average of all estimates.